GlassScriptPhysician profile
Lakai Robert Enterline
NPI 1922459452
$16,481.55
in general payments reported to CMS, 2019-2025
16 companies · $563 in 2025
The $563 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $115 · 2021: $6,392 · 2022: $8,521 · 2023: $17.50 · 2024: $506 · 2025: $563.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $715 · Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $714.50 |
| Food and Beverage | $372.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $10,830.42 | 2021-2024 | Bone Anchors With Arthroscopic Delivery System |
| Arthrex, INC. | $2,400.00 | 2022 | |
| Pinnacle, INC | $1,247.58 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $1,046.54 | 2019-2025 | Comprehensive Shoulder System, Persona |
| Stryker Corporation | $205.16 | 2022-2025 | Alphavent |
| Xiros INC | $172.58 | 2022 | |
| Baxter Healthcare | $114.78 | 2020 | |
| Depuy Synthes Sales INC. | $106.57 | 2019 | |
| Medacta USA, INC. | $93.33 | 2021 | |
| Heron Therapeutics, INC. | $83.33 | 2021 | |
| Ferring Pharmaceuticals INC. | $47.27 | 2025 | Euflexxa |
| Vericel Corporation | $40.69 | 2022-2023 | Maci |
| Wardlow Enterprises | $35.43 | 2022 | |
| Mf Med | $27.49 | 2025 | |
| Orthofix Medical, INC. | $15.48 | 2025 | Physio-Stim |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lakai Enterline listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.